The blastomogenic action of Sinestrol during intravaginal insertions.
D000236:Adenoma / Q000139:chemically induced*; D000284:Administration, Oral; D000818:Animals; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004716:Endometritis / Q000139:chemically induced / Q000473:pathology; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D005831:Genital Diseases, Female / Q000139:chemically induced*; D006965:Hyperplasia / Q000139:chemically induced / Q000473:pathology; D007279:Injections, Subcutaneous; D051379:Mice; D010212:Papilloma / Q000139:chemically induced / Q000473:pathology; D010911:Pituitary Neoplasms / Q000139:chemically induced*; D011422:Propionates / Q000008:administration & dosage; D051381:Rats; D013997:Time Factors; D014621:Vagina; D014625:Vaginal Neoplasms / Q000139:chemically induced / Q000473:pathology
D004967:Estrogens; D011422:Propionates; D004054:Diethylstilbestrol